Clinical Trial Update: Sofia 2 Lyme FIA Whole Blood Clinical Study

View source ↗

Summary

Clinical trial update for Quidel's Sofia 2 Lyme FIA Whole Blood test shows the study (NCT03238274) is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Snippet

Sponsor: Quidel Corporation | Conditions: Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans) | Status: COMPLETED